Top

Gepubliceerd in:

01-04-2007

What contributes more strongly to predicting QOL during 1-year recovery from treatment for clinically localized prostate cancer: 4-weeks-post-treatment depressive symptoms or type of treatment?

Auteurs: Patrick O. Monahan, Victoria Champion, Susan Rawl, R. Brian Giesler, Barbara Given, Charles W. Given, Debra Burns, Silvia Bigatti, Kristina M. Reuille, Faouzi Azzouz, Jingwei Wu, Michael Koch

Gepubliceerd in: Quality of Life Research | Uitgave 3/2007

vorige artikel Quality of life after radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma: comparison with transcatheter arterial chemoembolization alone

volgende artikel Examining predictive models of HRQOL in a population-based, multiethnic sample of women with breast carcinoma

Titel: What contributes more strongly to predicting QOL during 1-year recovery from treatment for clinically localized prostate cancer: 4-weeks-post-treatment depressive symptoms or type of treatment?
Auteurs: Patrick O. Monahan
Victoria Champion
Susan Rawl
R. Brian Giesler
Barbara Given
Charles W. Given
Debra Burns
Silvia Bigatti
Kristina M. Reuille
Faouzi Azzouz
Jingwei Wu
Michael Koch
Publicatiedatum: 01-04-2007
Uitgeverij: Kluwer Academic Publishers
Gepubliceerd in: Quality of Life Research / Uitgave 3/2007
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-006-9127-7

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Log in om toegang te krijgen

Andere artikelen Uitgave 3/2007

Psychometric properties of the initial Brazilian version of the CHQ-PF50 applied to the caregivers of children and adolescents with cerebral palsy

Structural validity and temporal stability of the 13-item sense of coherence scale: Prospective evidence from the population-based HeSSup study

Predictors of quality of life among women with coronary heart disease

Quality of life after radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma: comparison with transcatheter arterial chemoembolization alone

Responsiveness of disease-specific and generic utility instruments in prostate cancer patients

The social tariff of EQ-5D is not adequate to assess quality of life in patients with low back pain